The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
COVID
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- COVID-19 (127)
- COVID-19 vaccines (80)
- Advertising (76)
- Prescription medicines (33)
- Regulatory compliance (19)
- Alert/Advisory (15)
- Medicine safety (15)
- Safety (7)
- Disinfectants/Sterilants (6)
- Manufacturing (6)
- In Vitro Diagnostic medical devices (IVDs) (5)
- Labelling and packaging (3)
- Over the counter (OTC) medicines (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Shortages (2)
- Cosmetics (1)
- Import and export (1)
- Listed medicines (1)
- Medicinal cannabis hub (1)
- Non-prescription medicines (1)
- Scheduling (national classification system) (1)
Collection content
307 result(s) found, displaying 1 to 10
-
PageTo enable timely distribution of COVID-19 treatments, international labels may be used during initial supply in Australia.
-
PageInformation for sponsors and manufacturers wishing to make label claims of efficacy against COVID-19 for products that are either hard surface disinfectants or disinfectants that are medical devices.
-
PageBatch release testing of biological medicines (excluding vaccines) is no longer required.
-
PageCOVID-19 treatments that have provisional approval for use in Australia.
-
PageCOVID-19 treatments undergoing evaluation for provisional registration by the TGA.
-
PageCOVID-19 vaccines undergo evaluation for provisional and full registration by the TGA.
-
PageCOVID-19 vaccine batch release information is now available
-
GuidanceGuidance for hand sanitiser manufacturers, suppliers and advertisers about meeting their regulatory obligations.
-
GuidanceInformation to assist sponsors and manufacturers of products making antiviral claims determine if their product require an entry in the Australian Register of Therapeutic Goods (ARTG) to be legally imported and/or supplied in Australia.
-
GuidanceGuidance to assist sponsors and manufacturers in preparing their documentation for applications for COVID-19 rapid antigen tests.